Literature DB >> 9821701

Clinical survey of congenital cytomegalovirus infection in Japan.

M Morita1, T Morishima, T Yamazaki, S Chiba, T Kawana.   

Abstract

BACKGROUND: The clinical features of congenital cytomegalovirus (CMV) infection in countries with a higher percentage of maternal seropositivity for CMV has rarely been reported. We conducted a national survey for the first time in Japan to investigate the prevalence of congenital CMV infection.
METHODS: Questionnaires were sent in 1994 to pediatricians and obstetricians of 3398 hospitals with either more than 100 beds or a neonatal intensive care unit (NICU). The questionnaire asked for the number of new cases in 1992 and 1993, maternal status of CMV infection, diagnostic methods, clinical manifestations at birth, sequelae and prognosis.
RESULTS: A total of 46 cases of CMV infection were reported for the years 1992 and 1993 by 1448 hospitals; of these 39 were symptomatic. The annual incidence of symptomatic disease was 1.6 cases/100,000 live births. Major clinical manifestations such as low birthweight, hepatosplenomegaly, petechiae and intracranial calcification were noted at birth in 38-50% of symptomatic neonates. Sequelae, such as hearing loss, mental retardation and motor disability developed in 71% of survivors. Thirty-five percent of the 49 infected infants had either died or had severe disability. Several clinical manifestations at birth, including petechiae/thrombocytopenia, were significantly associated with severe sequelae or a poor prognosis.
CONCLUSION: The lower frequency of clinical findings at birth may be attributed to the higher seroprevalence of pregnant women in Japan than in Europe and the United States.

Entities:  

Mesh:

Year:  1998        PMID: 9821701     DOI: 10.1111/j.1442-200x.1998.tb01963.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  5 in total

Review 1.  Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

Authors:  Michael J Cannon; Paul D Griffiths; Van Aston; William D Rawlinson
Journal:  Rev Med Virol       Date:  2014-04-24       Impact factor: 6.989

2.  Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection.

Authors:  Ranjit I Kylat; Edmond N Kelly; Elizabeth Lee Ford-Jones
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

3.  Murine model for congenital CMV infection and hearing impairment.

Authors:  Chen Juanjuan; Feng Yan; Chen Li; Liu Haizhi; Wang Ling; Wang Xinrong; Xiao Juan; Liu Tao; Yin Zongzhi; Chen Suhua
Journal:  Virol J       Date:  2011-02-15       Impact factor: 4.099

4.  Delays in diagnosis and treatment initiation for congenital cytomegalovirus infection - Why we need universal screening.

Authors:  Styliani Alifieraki; Helen Payne; Chantal Hathaway; Rachel Wei Ying Tan; Hermione Lyall
Journal:  Front Pediatr       Date:  2022-09-14       Impact factor: 3.569

5.  GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes.

Authors:  Russell Cooper; Charles Dragar; Kate Elliot; J H Fitton; John Godwin; Ken Thompson
Journal:  BMC Complement Altern Med       Date:  2002-11-20       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.